Umbilical cord blood-derived cells

Korbling M, Robinson S, Estrov Z, et al. (2005). Umbilical cord blood-derived cells for tissue repair. Cytother. 7 258-261. [Pg.1359]

Keywords— Artificial porous scaffold, demineralized cancellous bone, decellularization, biocompatibility. Umbilical cord blood-derived cells (UCBDCs). [Pg.152]

Mayani H, Lansdorp PM, 1998. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Gells 16 153... [Pg.44]

Jeong, J. A., Hong, S. H., Gang, E. I, et al. (2005), Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray, Stem Cells, 23(4), 584-593. [Pg.115]

Other mechanistic approaches to cell therapy can also be envisioned, For example, a characteristic of compensated cardiac hypertrophy is the reduction of mechanical stress—a clear call for cells that are able to stabilize scar. Mesenchymal BM cells, fibroblasts, and skeletal myoblasts (all mesoderm-derived progenitors) improve diastolic function and reduce wall stress (30). The BN-MNC, peripheral blood endothelial progenitor cells (EPCs), and umbilical cord blood (UCB) cells... [Pg.425]

Sun W, Buzanska L, Domanska-Janik K, Salvi RJ, Stachowiak MK (2005) Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhe-matopoietic fraction of human umbilical cord blood. Stem Cells 23(7) 931-945... [Pg.371]

Umbilical Cord Blood-Derived Stem Cells (UCBSCs) 1346... [Pg.1313]

Umbilical cord blood-derived stem cells (UCBDSs)... [Pg.1333]

Umbilical Cord Blood-Derived Stem Cells (UCBSCs) Stem cells were isolated from umbilical cord blood (UCB) and cultured in vitro [215]. Umbilical cord blood-derived stem cells (UCBSCs) had been proposed as an alternative source of regeneration of hemopoietic tissue by allogeneic transplantation... [Pg.1346]

Schmidt D, Breymann C, Weber A, et al. (2004). Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann. Thorac. Surg. 78 2094-2098. [Pg.1359]

Leor J, Guetta E, Feinberg M S (2006). Human umbilical cord blood-derived CD133-I-cells enhance function and repair of the infarcted myocardium. Stem Cells. 24 772-780. [Pg.1359]

Gang E J, Hong S H, Jeong J A, et al. (2004). In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 321 102-108. [Pg.1360]

Byeon, Y.E., R3fu, H.H., Park, S.S., Koyama, Y., Kikuchi, M., et al., 2010. Paracrine effect of canine allogenic umbilical cord blood-derived mesenchymal stromal cells mixed with beta-tricalcium phosphate on bone regeneration in ectopic implantations. C3hotherapy 12, 626—636. Available from http //dx.doi.org/10.3109/14653249.2010.481665. [Pg.204]

Kim YS, Park IK, Kim WJ et al (2011) SPION nanoparticles as an efficient probe and carrita of DNA to umbilical cord blood-derived mesenchymal stem cells. J Nanosci Nanotechnol 11 1507-1510... [Pg.83]

Wang HY, Lun ZR, Lu SS. Cryopreservation of umbilical cord blood-derived mesenchymal stem cells without dimethyl sulfoxide. CryoLetters 201 l 32(l) 81-8. [Pg.170]

Trachea TE has been one of the most promising approaches to providing a potential clinical application for the treatment of long-segment tracheal stenosis. The sources of the cells are particularly important as the primary factor for TE. Besides autologous mature cells, various stem cells, including bone marrow-derived mesenchymal stem cells (MSCs), adipose tissue—derived stem cells, umbilical cord blood—derived mesenchymal stem cells, amniotic fluid stem cells, embryonic stem cells, and induced pluripotent stem cells, have received extensive attention in trachea TE [118]. [Pg.552]

The clinical potential of umbilical cord blood-derived stem and progenitor cells has been demonstrated, but the development and success of these therapies is limited by the need for increased cell numbers. Ex vivo expansion has been widely studied as a method to overcome this limitation. To be effective, cell therapy bioprocess design and optimization needs to incorporate a few basic criteria (Kirouac and Zandstra 2008) (i) assessment of relevant cell properties (ii) measurement and control of key parameters (hi) robust predictive strategies for interrogating and evaluating the many parameters that may... [Pg.436]

Bo Sun, Kyung-Hwan Roh, Sae-Rom Lee, Yong-Soon Lee, Kyung-Sun Kang. Indution of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure (2007). Biochemical and Biophysical Research Communication 354, 919 923... [Pg.166]

Gao F, Wu DQ, Hu YH, Jin GX. Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells.(2008) Chin Med J (Engl) 21 811-818. [Pg.166]

Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, Costa JJ, Galli SJ. IgE enhances FceRI expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood- derived mast cells synergistic effect of IL-4 and IgE on human mast cell FceRI expression and mediator release. J Immunol 1999 162 5455-5465. [Pg.66]

Buzanska, L., Stachowiak, E., Stachowiak, M. and Domanska-Janik, K. Neural stem cell line derived from human umbilical cord blood - morphological and functional properties. J. Neurochem. 85(Suppl. 2) 33, 2003. [Pg.515]

Cord blood derived embryonic-like stem cell derived from umbilical cord blood... [Pg.751]

Hematopoietic stem cell transplantation (HSCT) is a process that involves intravenous infusion of hematopoietic stem cells from a compatihle donor into a recipient, usually following administration of high-dose chemotherapy. Hematopoietic stem cells can be derived from the bone marrow, peripheral blood, or umbilical cord blood. The rationale for HSCT in the treatment of malignant disease is based on studies that show that most anticancer drugs have a steep... [Pg.2541]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...